A Randomized Controlled Trial of an Avatar-based Supportive Care Intervention for Patients Undergoing Outpatient Stem Cell Transplantation

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling (digital intervention or program) has been optimized for outpatient allogeneic hematopoietic stem cell transplantation (HCT), a randomized controlled trial (RCT) will be conducted of the digital versus usual supportive care program for outpatient HCT recipients. Potential improvements in anxiety and quality of life will be evaluated, with the intent of increasing comfortability with outpatient transplant and expanding the population of eligible patients willing to receive their transplants in an outpatient setting.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:

• Age 18+

• Seen for outpatient RIC HCT (prior to D0, generally D-6).

Locations
United States
Massachusetts
Dana-Farber Cancer Institute
RECRUITING
Boston
Contact Information
Primary
Chantal M Kerssens, PhD
chantal@friendi.fi
404-849-8323
Backup
Victor Wang, MS
victor@friendi.fi
415-866-6964
Time Frame
Start Date: 2024-10-21
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 90
Treatments
Experimental: care.coach Avatar™
care.coach Avatar™ with usual supportive care. The avatar program includes companionship, HCT educational modules, relaxation and mindfulness exercises, simple (seated) physical exercises, nightly check ins, and symptom self-management as needed.
No_intervention: Usual Supportive Care
Traditional supportive care comprising of a binder with HCT educational materials and regular meetings with a transplant nurse.
Related Therapeutic Areas
Sponsors
Collaborators: Dana-Farber Cancer Institute, care.coach corporation
Leads: Friendi.fi Corporation

This content was sourced from clinicaltrials.gov